LONDON--(BUSINESS WIRE)--Alexion, AstraZeneca Rare Disease has launched a new electronic storybook (e-book) to support children living with rare kidney disease, atypical Haemolytic Uraemic Syndrome ...
Novartis rolls out encouraging phase 2 data in rare kidney diseases with little competition in sight
Novartis rolled out results from two phase 2 clinical trials for investigational kidney disease medicine iptacopan that showed stabilization of kidney function in one and the reduction of a key marker ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results